Aclaris Therapeutics Inc logo

ACRS - Aclaris Therapeutics Inc Share Price

$1.84 -0.1  -6.6%

Last Trade - 17/01/20

Sector
Healthcare
Size
Small Cap
Market Cap £58.5m
Enterprise Value £11.5m
Revenue £6.28m
Position in Universe 4462nd / 6415
Bullish
Bearish
Unlock ACRS Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ACRS Revenue Unlock ACRS Revenue

Net Income

ACRS Net Income Unlock ACRS Revenue

Normalised EPS

ACRS Normalised EPS Unlock ACRS Revenue

PE Ratio Range

ACRS PE Ratio Range Unlock ACRS Revenue

Dividend Yield Range

ACRS Dividend Yield Range Unlock ACRS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ACRS EPS Forecasts Unlock ACRS Revenue
Profile Summary

Aclaris Therapeutics, Inc. is a dermatologist-led, biopharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological indications. The Company is also focused on the discovery and development of kinase inhibitors to treat inflammatory and immunological disorders and cancer. The Company’s drug discovery platform KINect technology is a kinase-focused drug discovery engine utilizing computational chemistry to integrate proprietary compound collections and highly experienced biologists and medicinal chemists to identify and advance potential candidates into preclinical and clinical development.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated July 13, 2012
Public Since October 7, 2015
No. of Shareholders: 71
No. of Employees: 169
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 41,388,432
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ACRS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ACRS
Upcoming Events for ACRS
Similar to ACRS
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.